Treatment Pathways and Outcomes in Patients with BMI ≥ 50 kg/m2: Conservative Treatment, Immediate Surgery or Stepwise Surgical Approach - Report - MDSpire

Treatment Pathways and Outcomes in Patients with BMI ≥ 50 kg/m2: Conservative Treatment, Immediate Surgery or Stepwise Surgical Approach

  • By

  • Sara Notz

  • Rainer Grotelueschen

  • Julia Pape

  • Bjoern-Ole Stueben

  • Louisa Stern

  • Julia Gerullies

  • Jonas Wagner

  • Anne Lautenbach

  • Jakob Robert Izbicki

  • Thilo Hackert

  • Philipp Busch

  • Anna Dupree

  • Dieter Weber

  • Oliver Mann

  • Gabriel Plitzko

  • July 18, 2025

  • 0 min

Share

Management Strategies and Outcomes for Patients with BMI ≥ 50 kg/m2

Overview

This study compared outcomes of conservative therapy, immediate bariatric surgery, and a stepwise approach in patients with BMI ≥ 50 kg/m2. Immediate surgery and stepwise treatment resulted in significantly greater weight loss and improvement in obesity-related comorbidities compared to conservative therapy alone.

Background

Obesity prevalence has risen dramatically worldwide, with high BMI recognized as a leading risk factor for morbidity and mortality. Patients with BMI ≥ 50 kg/m2 face unique surgical challenges and often require tailored treatment strategies. While bariatric surgery is the most effective long-term treatment, the role of preoperative conservative therapy remains controversial. Guidelines vary, with some recommending direct surgery for patients with BMI ≥ 50 kg/m2.

Data Highlights

GroupWeight Loss (%TWL)Weight Loss (%EWL)Comorbidity ImprovementFollow-up Duration
Non-Surg (Conservative)1.7–5.3 kg mean loss over 6 monthsNot significantMinimal improvement6 months
Surg-First (Immediate Surgery)Significant %TWL and %EWL at 6, 12, 24 monthsSignificantMarked improvement in T2DM, hypertension, OSASUp to 24 months
Step-Treat (Conservative + Surgery)Comparable to Surg-First at 24 monthsComparableSimilar comorbidity improvementsUp to 24 months

Key Findings

  • Conservative therapy alone resulted in minimal weight loss (1.7–5.3 kg) over 6 months with limited impact on comorbidities.
  • Immediate bariatric surgery led to significant and sustained weight loss (%TWL and %EWL) and improved obesity-related comorbidities.
  • Stepwise treatment (initial conservative therapy followed by surgery) achieved weight loss and comorbidity improvements comparable to immediate surgery at 24 months.
  • Technical challenges increase with BMI ≥ 50 kg/m2, often limiting surgical options to sleeve gastrectomy.
  • Preoperative weight loss did not consistently predict better postoperative outcomes.
  • Some guidelines recommend direct surgery for BMI ≥ 50 kg/m2, while others mandate preoperative conservative therapy despite limited efficacy.

Clinical Implications

For patients with BMI ≥ 50 kg/m2, immediate bariatric surgery or a stepwise approach incorporating surgery after conservative treatment yields superior weight loss and comorbidity resolution compared to conservative therapy alone. Preoperative conservative therapy may not significantly enhance surgical outcomes but is often required by insurers or guidelines. Surgical planning should consider technical challenges and patient-specific factors to optimize outcomes.

Conclusion

In individuals with BMI ≥ 50 kg/m2, bariatric surgery—either immediate or following conservative treatment—provides substantially better weight loss and health improvements than conservative management alone. Treatment strategies should prioritize timely surgical intervention to maximize benefits.

References

  1. World Health Organization 2016 -- Global Obesity Trends
  2. IFSO Guidelines 2019 -- Indications for Bariatric Surgery
  3. Meta-analyses 2020 -- Preoperative Weight Loss Efficacy
  4. German and NICE Guidelines 2021 -- Surgical Criteria for BMI ≥ 50

Original Source(s)

Related Content